Expression of ID family genes in the synovia from patients with rheumatoid arthritis

D Sakurai1, A Yamaguchi, N Tsuchiya

  • 1Department of Human Genetics, University of Tokyo, Tokyo, Japan.

Insights

Inhibitor of differentiation (ID) genes ID1 and ID3 are significantly elevated in rheumatoid arthritis (RA) synovium, suggesting a role in the inflammatory disease

Area of Science:

  • Molecular Biology
  • Immunology
  • Pathogenesis of Arthritis

Background:

  • Rheumatoid arthritis (RA) is a chronic inflammatory condition marked by synovial tissue proliferation, leading to cartilage and bone destruction.
  • Identifying key molecular players in RA pathogenesis is crucial for understanding disease mechanisms.

Purpose of the Study:

  • To investigate the differential expression of genes, specifically ID1 (inhibitor of differentiation 1) and other Id family members, in rheumatoid arthritis (RA) synovium compared to osteoarthritis (OA).
  • To explore the potential role of upregulated ID genes in the angiogenesis characteristic of RA.

Main Methods:

  • Differential display technique was employed to compare mRNA expression patterns between RA and OA synovial tissues.
  • Semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) was used to analyze mRNA levels of ID1 and ID3 in synovial tissues from RA and OA patients.
  • Immunohistochemistry was performed to localize the expression of Id1 and Id3 proteins within the synovial tissue.

Main Results:

  • mRNA levels of ID1 and ID3 were significantly higher in RA synovia (8.6-fold and 3.3-fold, respectively) compared to OA synovia.
  • Immunohistochemical analysis showed prominent Id1 and Id3 staining in endothelial cells of RA synovium, indicating a potential role in angiogenesis.
  • The study identified a novel finding of Id family gene expression in the synovium.

Conclusions:

  • Upregulation of ID1 and ID3 genes in RA synovium suggests their involvement in the pathogenesis of rheumatoid arthritis.
  • The expression of Id proteins in endothelial cells points to a potential role in the severe angiogenesis observed in RA.
  • Further research is needed to elucidate the functional significance and genetic contribution of Id family genes in RA susceptibility.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Development of the Limb Synovial Joints01:07

Development of the Limb Synovial Joints

Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...